Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

High definition analyses of single cohort, whole genome sequencing data provides a direct route to defining sub-phenotypes and personalising medicine

View ORCID ProfileKE Joyce, E Onabanjo, S Brownlow, F Nur, KO Olupona, View ORCID ProfileK Fakayode, View ORCID ProfileM Sroya, G Thomas, T Ferguson, View ORCID ProfileJ Redhead, CM Millar, N Cooper, DM Layton, View ORCID ProfileF Boardman-Pretty, View ORCID ProfileMJ Caulfield, Genomics England Research Consortium, View ORCID ProfileCL Shovlin
doi: https://doi.org/10.1101/2021.08.28.21262560
KE Joyce
1Imperial College School of Medicine, Imperial College, London UK
2Genomics England Respiratory Clinical Interpretation Partnership (GeCIP)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for KE Joyce
E Onabanjo
3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Brownlow
3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Nur
3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KO Olupona
3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Fakayode
3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for K Fakayode
M Sroya
4Department of Surgery and Cancer, Imperial College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M Sroya
G Thomas
4Department of Surgery and Cancer, Imperial College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T Ferguson
3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Redhead
3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J Redhead
CM Millar
3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London UK
5Centre for Haematology, Department of Immunology and Inflammation, Imperial College London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N Cooper
3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London UK
5Centre for Haematology, Department of Immunology and Inflammation, Imperial College London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DM Layton
3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London UK
5Centre for Haematology, Department of Immunology and Inflammation, Imperial College London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Boardman-Pretty
6Genomics England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F Boardman-Pretty
MJ Caulfield
6Genomics England, UK
7William Harvey Research Institute, Queen Mary University of London, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for MJ Caulfield
6Genomics England, UK
CL Shovlin
2Genomics England Respiratory Clinical Interpretation Partnership (GeCIP)
3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London UK
8National Heart and Lung Institute, Imperial College London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for CL Shovlin
  • For correspondence: c.shovlin{at}imperial.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Possession of a clinical or molecular disease label alters the context in which life-course events operate, but rarely explains the phenotypic variability observed by clinicians. Whole genome sequencing of unselected endothelial vasculopathy patients demonstrated more than a third had rare, likely deleterious variants in clinically-relevant genes unrelated to their vasculopathy (1 in 10 within platelet genes; 1 in 8 within coagulation genes; and 1 in 4 within erythrocyte hemolytic genes). High erythrocyte membrane variant rates paralleled genomic damage and prevalence indices in the general population. In blinded analyses, patients with greater hemorrhagic severity that had been attributed solely to their vasculopathy had more deleterious variants in platelet (Spearman ρ=0.25, p=0.008) and coagulation (Spearman ρ=0.21, p=0.024) genes. We conclude that rare diseases can provide insights for medicine beyond their primary pathophysiology, and propose a framework based on rare variants to inform interpretative approaches to accelerate clinical impact from whole genome sequencing.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Not relevant

Funding Statement

This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research (NIHR) and NHS England. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Ethics Advisory Committee for the 100,000 Genomes Project: for further detail, see https://www.genomicsengland.co.uk/about-genomics-england/the-board/ethics-advisory-committee/)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data Availability Statement Primary data from the 100,000 Genomes Project, which are held in a secure Research Environment, are available to registered users. Please see https://www.genomicsengland.co.uk/about-gecip/for-gecip-members/data-and-data-access for further information.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 01, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
High definition analyses of single cohort, whole genome sequencing data provides a direct route to defining sub-phenotypes and personalising medicine
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High definition analyses of single cohort, whole genome sequencing data provides a direct route to defining sub-phenotypes and personalising medicine
KE Joyce, E Onabanjo, S Brownlow, F Nur, KO Olupona, K Fakayode, M Sroya, G Thomas, T Ferguson, J Redhead, CM Millar, N Cooper, DM Layton, F Boardman-Pretty, MJ Caulfield, Genomics England Research Consortium, CL Shovlin
medRxiv 2021.08.28.21262560; doi: https://doi.org/10.1101/2021.08.28.21262560
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
High definition analyses of single cohort, whole genome sequencing data provides a direct route to defining sub-phenotypes and personalising medicine
KE Joyce, E Onabanjo, S Brownlow, F Nur, KO Olupona, K Fakayode, M Sroya, G Thomas, T Ferguson, J Redhead, CM Millar, N Cooper, DM Layton, F Boardman-Pretty, MJ Caulfield, Genomics England Research Consortium, CL Shovlin
medRxiv 2021.08.28.21262560; doi: https://doi.org/10.1101/2021.08.28.21262560

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)